LATEST ALERTS
The US FDA has taken a step closer to regulating nicotine levels in combustible cigarettes, but excluded vapour products from its proposals, even predicting a low-nicotine regime might encourage smokers toward electronic alternatives
The US FDA has made some public amendments to PMI’s reduced risk applications for IQOS and three types of Marlboro HeatSticks products
British American Tobacco claims to be the largest reduced-risk product company in the world following its acquisition of Reynolds American and says it will build on this through a variety of HnB, moist tobacco and oral tobacco brands
As tobacco giants Philip Morris International (PMI) and Japan Tobacco (JT) have been hit by falling tobacco sales, revenues from their e-cigarette and heat-not-burn (HnB) portfolios have increased
Agency’s science committee agrees that PMI product decreases exposure to dangerous chemicals, but won’t accept broader claims of long-term risk reduction
As the US FDA gets to grips with its new focus on nicotine as a single marketplace, it is planning to take a fresh look at one of the longest-established non-combustible forms of the substance – nicotine replacement therapy
ECigIntelligence’s review of the year gone by reflects the big stories of the e-cigarette world in 2017, the trends in regulation, the developing and diverging markets, the science and innovation, and peers into the crystal ball to consider where it all goes from here
The US Food and Drug Administration (FDA) will have to consider again next year the possibility that snus could be a reduced-risk form of tobacco, following a series of applications from R.J. Reynolds Tobacco Company
E-cigarettes could be taxed at the same level as cigarettes if a new US proposal passes into law. TobaccoIntelligence believes this attempt is likely to fail
The US FDA has missed its own 180-day deadline for replying to the premarket tobacco application (PMTA) by Philip Morris International for its IQOS heated tobacco products
The American Vaping Association has written to FDA commissioner Scott Gottlieb urging him to approve PMI’s heated tobacco product iQOS for sale in the US
A move by the US FDA to reduce the nicotine content in cigarettes to non-addictive levels could encourage Big Tobacco to put yet more effort into alternatives
Scott Gottlieb, commissioner of the US FDA, appeared on Friday to go further than any federal official – or most politicians – previously had in supporting alternative nicotine products for harm reduction
The $49.4bn takeover of Reynolds American by British American Tobacco (BAT) is set to go through next week after being approved by shareholders of both companies.
New research shines a little light on how Japanese consumers are reacting to iQOS, and how HnB products compare with both combustibles and e-cigarettes on the crucial question of nicotine delivery.
PMI has responded forcefully after a Swiss research team claimed its iQOS heat-not-burn system released “the same harmful constituents of conventional cigarette smoke”
Philip Morris International (PMI) has submitted its iQOS heat-not-burn system for approval by the U.S. Food and Drug Administration (FDA).
Altria is set to take a digital approach to launching its iQOS heat-not-burn product in the U.S. but there will be significant costs along the way.
Swedish Match has at last obtained some answers from the U.S. Food and Drug Administration (FDA) on its attempt to have snus smokeless tobacco products classified as modified risk
Philip Morris International (PMI) this week submitted its iQOS technology for approval as a reduced-risk product by the U.S. Food and Drug Administration (FDA)
Pax Labs, the U.S. heat-not-burn manufacturer previously known as Ploom, today launches a new generation of its namesake device which it is positioning as “the most intelligent, premium and highest performing vaporizer in the market”.
U.S. startup Ploom and its investor Japan Tobacco International (JTI) are to end their relationship and divide Ploom’s products between them.
U.S. tobacco maker Reynolds American is preparing to test-market a heat-not-burn product which it hopes the regulator will approve as reduced-risk.
Philip Morris International (PMI) will no longer be conspicuous in the tobacco alternatives market by its absence
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the TobaccoIntelligence team.
